Cancer
Study links graying hair and melanoma to stress responses in pigment stem cells
Heather Vogel Larawang ginawa ng AI Fact checked
Japanese researchers report that hair graying and melanoma can arise from the same melanocyte stem cells, which take different paths depending on DNA damage and local signals. Published online October 6, 2025 in Nature Cell Biology, the University of Tokyo-led study outlines a protective differentiation program that promotes graying and how carcinogens can subvert it to favor melanoma.
Study confirms rise in cancer cases among adults under 50
A new international analysis reveals an increase in six types of cancer among adults aged 20 to 49 in 42 countries, mainly linked to obesity and sedentarism. Except for colorectal cancer, these tumors are also rising in those over 50. Experts urge investigating causes and enhancing prevention.
Weaponised CAR T-cell therapy eradicates prostate tumours in mice
October 20, 2025 00:10Study shows lipids fuel triple-negative breast cancer growth
October 20, 2025 00:10COVID mRNA vaccine boosts survival in advanced cancer patients
October 20, 2025 00:10Breastfeeding boosts immune cells that may prevent breast cancer
October 18, 2025 00:14Bile acids hinder liver cancer immunotherapy, supplement may help
October 07, 2025 00:44Antonia San Juan explains why she shares her cancer on social media
October 07, 2025 00:21El Paso residents probe warehouse ethylene oxide emissions
October 07, 2025 00:16Glioblastoma erodes skull and disrupts immune system, study reveals
Andalusia's government dismisses health counselor over breast cancer screening errors
Iniulat ng AI Larawang ginawa ng AI
Andalusia's regional president, Juanma Moreno, has announced the dismissal of Health Counselor Rocío Hernández following errors in the breast cancer screening program affecting about 2,000 women. The move comes amid massive protests in Seville and opposition calls for an investigation. The government has launched an emergency plan to review pending cases.
COVID-19 mRNA vaccines linked to longer survival in some lung and skin cancer patients on immunotherapy
Heather Vogel Fact checked
A large retrospective study from the University of Florida and The University of Texas MD Anderson Cancer Center, published in Nature, reports that patients with advanced non-small cell lung cancer or metastatic melanoma lived significantly longer if they received a Pfizer-BioNTech or Moderna COVID-19 mRNA shot within 100 days of starting immune checkpoint inhibitors. The authors stress the findings are observational and will require confirmation in randomized trials.
Thousands protest in seville against breast cancer screening failures
Carmen González Larawang ginawa ng AI
Thousands gathered on Sunday in front of the Palacio de San Telmo in Seville to protest failures in breast cancer screenings in Andalusia and demand the resignation of Junta president Juan Manuel Moreno. Organized by the Amama association, the event highlights the deterioration of public health and impacts at least 2,317 women not informed of their results. The Andalusian government offers dialogue, while the PP labels the rally a failure.
Immune drug reduces risk of Merkel cell carcinoma spread
A large clinical trial has shown that the immunotherapy drug pembrolizumab may help prevent the deadly spread of Merkel cell carcinoma, a rare and aggressive skin cancer, after surgery. While it did not significantly reduce overall recurrence rates, the treatment lowered the risk of distant metastases by 42%. The findings offer hope for patients facing this fast-developing disease.
mRNA covid vaccines may boost cancer immunotherapy survival
An analysis of nearly 1,000 cancer patients shows that mRNA covid-19 vaccines, given soon after starting immune checkpoint inhibitors, nearly doubled survival times for advanced lung and skin cancers. The findings, presented at a medical congress in Berlin, suggest an unexpected immune boost from the vaccines. A clinical trial to confirm these results is set to begin before year's end.
Biden undergoes radiation therapy for prostate cancer
Iniulat ng AI
Former President Joe Biden has begun radiation therapy as part of his treatment for an aggressive form of metastatic prostate cancer diagnosed in May 2025. A spokesperson confirmed he is also receiving hormone treatment and described him as doing well. The cancer, which spread to his bones, was detected after urinary symptoms prompted a scan.